Терапевтический архив (Mar 2011)

Efficacy of immunovenin in patients with community-acquired pneumonia

  • Usman Raul'evich Farkhutdinov,
  • Al'bert Marsel'evich Mirkhaydarov,
  • Rafagat Ravil'evich Farkhutdinov,
  • Shamil' Usmanovich Farkhutdinov,
  • U R Farkhutdinov,
  • A M Mirkhaidarov,
  • R R Farkhutdinov,
  • Sh U Farkhutdinov

Journal volume & issue
Vol. 83, no. 3
pp. 40 – 44

Abstract

Read online

Aim. To study efficacy of human immunoglobulin for intravenous administration (immunovenin) in the treatment of patients with community-acquired pneumonia (CAP). Material and methods. Two groups of CAP patients participated in the trial. Group 1 (n = 35) received standard therapy. Group 2 (n = 33) received standard therapy plus immunovenin. Results. CAP patients had immune disorders.Combined treatment of CAP with administration of immunovenin relieved clinical symptoms of the disease, improved immunological status. Group 1 patients demonstrated symptoms of the disease and defects in immunity for a long time. Conclusion. Addition of immunovenin to standard therapy of CAP improves immunological parameters, efficacy of CAP treatment.

Keywords